Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inactivators of cytochrome P450.
Arylalkynes such as 4-phenyl-1-butyne (PBY), 5-phenyl-1-pentyne (PPY) and 2-ethynylnaphthalene (2-EN) are suicide inhibitors of cytochrome P450 enzymes. Arylalkyl isothiocyanates such as 6-phenylhexyl isothiocyanate (PHITC) are structurally related to arylalkynes and are known to inhibit the cytochrome P450 mediated metabolic activation and tumorigenicity of a tobacco-specific lung carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). In this study, we compared the ability of PBY, PPY, 2-EN and PHITC to inhibit A/J mouse lung tumorigenesis by NNK. Groups of 20 female mice were gavaged with 5 mumol of arylalkyne or PHITC in corn oil. Two hours later they were given a single i.p. injection of 10 mumol NNK. The mice were killed 16 weeks later. PPY and PHITC were both potent inhibitors of tumorigenesis by NNK, reducing lung tumor multiplicity from 8.35 tumors per mouse to 0.40 and 0.35 respectively. PBY and 2-EN also significantly inhibited tumor multiplicity. The results of this study demonstrate that arylalkynes and PHITC are potent inhibitors of NNK induced lung tumorigenesis in A/J mice, consistent with the hypothesis that inhibition of specific cytochrome P450 enzymes is involved in inhibition of tumorigenesis.
Alworth
W L
WL
Department of Chemistry, Tulane University, New Orleans, LA 70118.
Young-Sciame
R
R
Hecht
S S
SS
D000480:Alkynes / Q000627:therapeutic use*; D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use* / Q000633:toxicity; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D017879:Isothiocyanates; D008175:Lung Neoplasms / Q000139:chemically induced / Q000201:enzymology* / Q000517:prevention & control*; D051379:Mice; D008805:Mice, Inbred A; D009281:Naphthalenes / Q000627:therapeutic use; D009602:Nitrosamines / Q000037:antagonists & inhibitors* / Q000633:toxicity; D013861:Thiocyanates / Q000627:therapeutic use
D000480:Alkynes; D016588:Anticarcinogenic Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D017879:Isothiocyanates; D009281:Naphthalenes; D009602:Nitrosamines; D013861:Thiocyanates; C073279:6-phenylhexyl isothiocyanate; C065012:2-ethynylnaphthalene; C016583:4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; D003577:Cytochrome P-450 Enzyme System